These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3948988)

  • 1. [Anti-anginal action of antihypoxants].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1986; 49(1):52-6. PubMed ID: 3948988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective action on the myocardium of antihypoxants in acute occlusion and subsequent reperfusion of the coronary artery].
    Lomtadze DM; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1990; 53(2):31-4. PubMed ID: 2369950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of preparations with antihypoxic properties on ischemic damage to the myocardium].
    Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Nov; 102(11):585-7. PubMed ID: 3779087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of antihypoxic agents on the blood supply and function of the intact and ischemic myocardium].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1985; 48(2):49-54. PubMed ID: 3996570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The long-term use of antihypoxants in myocardial infarct in rats: their effect on the hemodynamics and contractile function of the heart].
    Tsorin IB; Kazanova GV; Chichkanov GG
    Eksp Klin Farmakol; 1993; 56(3):25-7. PubMed ID: 8219984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The absence of a parallelism between the antihypoxic and anti-ischemic actions of pharmacological agents].
    Lomtadze DM; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):27-9. PubMed ID: 1915815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative assessment of the blood supply to the focus of myocardial ischemia in dogs in pharmacological research].
    Matsievskiĭ DD; Lyskovtsev VV; Grigor'eva EK; Zbrizher EA; Chichkanov GG
    Biull Eksp Biol Med; 1988 Nov; 106(11):531-3. PubMed ID: 2973817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia].
    Chichkanov GG; Bogolepov AK; Matsievskiĭ DD
    Kardiologiia; 1981 Oct; 21(10):85-8. PubMed ID: 6117671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of sodium oxybutyrate on the blood supply and activity of the normal and ischemic myocardium].
    Chichkanov GG; Bogolepov AK; Tsorin IB; Matsievskiĭ DD
    Biull Eksp Biol Med; 1982 Mar; 93(3):44-7. PubMed ID: 7093482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protective effect of lithium oxybutyrate on the ischemic myocardium].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Lomtadze DM
    Biull Eksp Biol Med; 1988 Jan; 105(1):46-8. PubMed ID: 3337880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The protective action of vasocyclin (prostacyclin) on the ischemic myocardium].
    Kazanova GV; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):24-7. PubMed ID: 1915814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment concepts for stable angina pectoris in coronary heart disease].
    Schoebel FC; Leschke M; Heintzen MP; Strauer BE
    Med Klin (Munich); 1996 Jul; 91(7):458-65. PubMed ID: 8756115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preclinical evaluation of the antianginal activity of energy metabolism intermediates].
    Kostin VI
    Farmakol Toksikol; 1989; 52(6):49-52. PubMed ID: 2560436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic use of piracetam in myocardial infarct patients].
    Leshchinskiĭ LA; Pimenov LT; Fedorov VS
    Kardiologiia; 1987 Feb; 27(2):46-50. PubMed ID: 3573522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of the effect of nimodipine and flunarizine on the intact and ischemic myocardium].
    Kazanova GV; Kirsanova GIu; Tsorin IB; Chichkanov GG
    Farmakol Toksikol; 1990; 53(3):13-5. PubMed ID: 2387372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.